-
Symbol
-
GPCR on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
6,492,435 shares
-
Security Ownership %
-
3.8%
Shares, Excluding Options vs Price
Capital Research Global Investors ownership in Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR)
13 May 2025 - Capital Research Global Investors has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,492,435 shares of Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR).
This represents 3.8% ownership of the company.
This is the first filing by Capital Research Global Investors disclosing ownership of Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.